US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bausch + Lomb Corp.

15.65

+0.06000.38%

Post-market: 15.740.0900+0.58%18:37 EDT

Volume:819.82K

Turnover:12.82M

Market Cap:5.58B

PE:-25.18

High:15.71

Open:15.55

Low:15.43

Close:15.59

52wk High:18.92

52wk Low:11.22

Shares:356.38M

Float Shares:42.05M

Volume Ratio:2.59

T/O Rate:1.95%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6214

EPS(LYR):-1.0200

ROE:-3.28%

ROA:1.42%

PB:0.87

PE(LYR):-15.34

Loading ...

Overview Company News Filings

Earning Preview: Bausch + Lomb Corp. this quarter’s revenue is expected to increase by 5.82%, and institutional views are mostly bullish

Bausch + Lomb announces availability of 2025 Sustainability Impact Report

Bausch Health publishes 2025 annual report

Bausch + Lomb receives FDA 510k clearance for Bi-Blade+

Bausch + Lomb wins FDA clearance for Bi-Blade+ vitrectomy cutter

Bausch + Lomb Launches enVista Envy Intraocular Lenses in Europe

MT Newswires Live

Bausch + Lomb unveils new clinical data on cataract, dry eye portfolio at ASCRS meeting

Bausch + Lomb to report first-quarter financial results, host conference call and webcast

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday

MT Newswires Live

Bausch + Lomb reports 24-month U.S. ELIOS glaucoma trial results with 76% achieving ≥20% IOP reduction

Is Bausch + Lomb’s Glaucoma Focus Reframing Its Innovation Story for Investors (BLCO)?

Simply Wall St.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evotec AG (EVO), Shoulder Innovations, Inc. (SI) and Bausch + Lomb Corporation (BLCO)

A Look At Bausch + Lomb (NYSE:BLCO) Valuation As Glaucoma Pipeline Webinar Draws Fresh Attention

Simply Wall St.

Cooper Companies raises 2026 profit forecast on demand for disposable contact lenses

Morgan Stanley Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)

Bausch + Lomb Director Andrew C. von Eschenbach Acquires Common Shares

US Treasury chief says FedEx should say how consumers will get tariff rebates

Bausch + Lomb Director Steven H. Collis Acquires Common Shares

L'Oreal, Dyson, Bausch + Lomb become the latest to sue for Trump tariff refunds

Study finds Bausch + Lomb’s LUMIFY reduces eye redness without rebound or tachyphylaxis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BLCO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLCO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLCO\",,,,,undefined,":{"symbol":"BLCO","market":"US","secType":"STK","nameCN":"Bausch + Lomb Corp.","latestPrice":15.65,"timestamp":1780084800000,"preClose":15.59,"halted":0,"volume":819818,"hourTrading":{"tag":"盘后","latestPrice":15.74,"preClose":15.65,"latestTime":"18:37 EDT","volume":64247,"amount":1006707.0905,"timestamp":1780094272423,"change":0.09,"changeRate":0.005751,"amplitude":0.003834},"delay":0,"changeRate":0.0038486209108403143,"floatShares":42050685,"shares":356382628,"eps":-0.621433,"marketStatus":"Market Closed","change":0.06,"latestTime":"05-29 16:00:00 EDT","open":15.55,"high":15.71,"low":15.4301,"amount":12824030.938811999,"amplitude":0.017954,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.621433,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"listingDate":1651809600000,"exchange":"NYSE","adjPreClose":15.59,"postHourTrading":{"tag":"盘后","latestPrice":15.74,"preClose":15.65,"latestTime":"18:37 EDT","volume":64247,"amount":1006707.0905,"timestamp":1780094272423,"change":0.09,"changeRate":0.005751,"amplitude":0.003834},"volumeRatio":2.5881492002663835,"impliedVol":0.4049,"impliedVolPercentile":0.4582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLCO\",,,,,undefined,":{"symbol":"BLCO","floatShares":42050685,"roa":"1.42%","roe":"-3.28%","lyrEps":-1.02,"volumeRatio":2.5881492002663835,"shares":356382628,"dividePrice":0,"high":15.71,"amplitude":0.017954,"preClose":15.59,"low":15.4301,"week52Low":11.22,"pbRate":"0.87","psRate":"1.07","week52High":18.915,"institutionHeld":0,"latestPrice":15.65,"eps":-0.621433,"divideRate":0,"volume":819818,"delay":0,"ttmEps":-0.621433,"open":15.55,"prevYearClose":17.08,"prevWeekClose":15.92,"prevMonthClose":15.9,"prevQuarterClose":15.9,"fiveDayClose":16.15,"twentyDayClose":15.9,"sixtyDayClose":18.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLCO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-04-29","symbol":"BLCO","fiscalQuarterEnding":"2026/03","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1777435200000,"reportTimeType":"pre","actualEps":0.08},{"date":"2026-02-18","symbol":"BLCO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":0.35,"defaultRemindTime":1771405200000,"name":null,"time":"Pre-Market","dateTimestamp":1771390800000,"actualEps":null},{"market":"US","date":"2025-10-29","symbol":"BLCO","fiscalQuarterEnding":"2025/09","expectedEps":0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1761710400000,"reportTimeType":"pre","actualEps":0.18},{"market":"US","date":"2025-07-30","symbol":"BLCO","fiscalQuarterEnding":"2025/06","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"pre","actualEps":0.07},{"market":"US","date":"2025-04-30","symbol":"BLCO","fiscalQuarterEnding":"2025/03","expectedEps":0.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"pre","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLCO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLCO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0769,"buy":0.2308,"hold":0.6154,"sell":0.0769,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6154,"analysts":13,"updateTime":1771473600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLCO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLCO","date":"2026-05-29","current":-25.183729,"percent":0.182281,"low":-70.745867,"twenty":-24.19338,"median":-16.678429,"eighty":33.445692,"high":1085.002892,"avg":38.936196,"sd":210.581376,"marketCap":5558401821},"quantilePoints":[{"date":"2022-05-06","current":38.461538,"twenty":38.461538,"median":38.461538,"eighty":38.461538,"marketCap":7000000000},{"date":"2022-05-13","current":34.076923,"twenty":33.596154,"median":33.913461,"eighty":34.615385,"marketCap":6202000000},{"date":"2022-05-20","current":34.36,"twenty":33.596154,"median":34.076923,"eighty":34.615385,"marketCap":6013000000},{"date":"2022-05-27","current":35.38,"twenty":33.596154,"median":34.038461,"eighty":35.04,"marketCap":6191500000},{"date":"2022-06-03","current":33.22,"twenty":32.932,"median":33.99,"eighty":34.700308,"marketCap":5813500000},{"date":"2022-06-10","current":28.14,"twenty":32.141385,"median":33.75,"eighty":34.491077,"marketCap":4924500000},{"date":"2022-06-17","current":31.5,"twenty":29.752,"median":33.12,"eighty":34.38,"marketCap":5512500000},{"date":"2022-06-24","current":31.7,"twenty":30.468,"median":32.57,"eighty":34.190154,"marketCap":5547500000},{"date":"2022-07-01","current":31.72,"twenty":30.304,"median":32.22,"eighty":34.042769,"marketCap":5551000000},{"date":"2022-07-08","current":32.86,"twenty":30.512,"median":31.94,"eighty":34.012,"marketCap":5750500000},{"date":"2022-07-15","current":31.18,"twenty":30.712,"median":31.95,"eighty":33.992,"marketCap":5456500000},{"date":"2022-07-22","current":30.66,"twenty":30.512,"median":31.826923,"eighty":33.916,"marketCap":5365500000},{"date":"2022-07-29","current":28.78,"twenty":30.512,"median":31.813462,"eighty":33.792,"marketCap":5036500000},{"date":"2022-08-05","current":39.915441,"twenty":30.288,"median":31.8,"eighty":33.916,"marketCap":5428500000},{"date":"2022-08-12","current":42.102941,"twenty":30.372,"median":31.91,"eighty":34.246769,"marketCap":5726000000},{"date":"2022-08-19","current":39.889706,"twenty":30.512,"median":32.14,"eighty":35.244,"marketCap":5425000000},{"date":"2022-08-26","current":40.069853,"twenty":30.568,"median":32.27,"eighty":39.879412,"marketCap":5449500000},{"date":"2022-09-02","current":38.602941,"twenty":30.612,"median":32.56,"eighty":39.513971,"marketCap":5250000000},{"date":"2022-09-09","current":44.1875,"twenty":30.668,"median":32.86,"eighty":39.889706,"marketCap":6009500000},{"date":"2022-09-16","current":45.216912,"twenty":30.7,"median":33.2,"eighty":40.131618,"marketCap":6149500000},{"date":"2022-09-23","current":41.047794,"twenty":30.748,"median":33.75,"eighty":41.109559,"marketCap":5582500000},{"date":"2022-09-30","current":39.477941,"twenty":30.952,"median":33.99,"eighty":41.109559,"marketCap":5369000000},{"date":"2022-10-07","current":40.224351,"twenty":31.004,"median":34.076923,"eighty":41.624265,"marketCap":5470511706},{"date":"2022-10-14","current":37.805228,"twenty":31.052,"median":34.537693,"eighty":41.526471,"marketCap":5141511002},{"date":"2022-10-21","current":38.371406,"twenty":31.204,"median":35.38,"eighty":41.330882,"marketCap":5218511167},{"date":"2022-10-28","current":37.419198,"twenty":31.32,"median":37.329124,"eighty":41.109559,"marketCap":5089010890},{"date":"2022-11-04","current":89.612261,"twenty":31.408,"median":37.419198,"eighty":41.526471,"marketCap":5197511122},{"date":"2022-11-11","current":92.207094,"twenty":31.452,"median":37.612213,"eighty":41.819853,"marketCap":5348011444},{"date":"2022-11-18","current":90.517435,"twenty":31.52,"median":37.985375,"eighty":42.092647,"marketCap":5250011235},{"date":"2022-11-25","current":89.491571,"twenty":31.6,"median":38.216912,"eighty":42.514706,"marketCap":5190511107},{"date":"2022-12-02","current":93.413993,"twenty":31.7,"median":38.319894,"eighty":43.75,"marketCap":5418011594},{"date":"2022-12-09","current":91.784679,"twenty":31.72,"median":38.461538,"eighty":44.1875,"marketCap":5323511392},{"date":"2022-12-16","current":89.732951,"twenty":31.8,"median":38.795956,"eighty":81.465692,"marketCap":5204511137},{"date":"2022-12-23","current":88.345017,"twenty":31.826923,"median":39.349349,"eighty":87.741567,"marketCap":5124010965},{"date":"2022-12-30","current":93.595028,"twenty":31.869385,"median":39.658088,"eighty":88.369155,"marketCap":5428511616},{"date":"2023-01-06","current":97.336415,"twenty":31.916,"median":39.863971,"eighty":89.032949,"marketCap":5645512081},{"date":"2023-01-13","current":100.112283,"twenty":31.952,"median":39.902574,"eighty":89.310536,"marketCap":5806512425},{"date":"2023-01-20","current":103.310566,"twenty":32.032,"median":40.069853,"eighty":89.684675,"marketCap":5992012822},{"date":"2023-01-27","current":103.793326,"twenty":32.156,"median":40.172794,"eighty":90.855367,"marketCap":6020012882},{"date":"2023-02-03","current":104.33643,"twenty":32.196,"median":40.250086,"eighty":91.567437,"marketCap":6051512950},{"date":"2023-02-10","current":100.232973,"twenty":32.26,"median":40.533088,"eighty":91.929507,"marketCap":5813512440},{"date":"2023-02-17","current":114.112373,"twenty":32.352,"median":41.086397,"eighty":92.158818,"marketCap":6618517643},{"date":"2023-02-24","current":1069.25285,"twenty":32.432,"median":41.472426,"eighty":93.462269,"marketCap":6415517101},{"date":"2023-03-03","current":1036.002762,"twenty":32.564,"median":41.794118,"eighty":96.213999,"marketCap":6216016570},{"date":"2023-03-10","current":927.502472,"twenty":32.636,"median":41.884191,"eighty":97.565726,"marketCap":5565014834},{"date":"2023-03-17","current":926.335803,"twenty":32.892,"median":42.051471,"eighty":99.90711,"marketCap":5558014816},{"date":"2023-03-24","current":928.085807,"twenty":33.052,"median":42.411765,"eighty":101.186423,"marketCap":5568514844},{"date":"2023-03-31","current":1015.58604,"twenty":33.188,"median":42.617647,"eighty":102.743323,"marketCap":6093516243},{"date":"2023-04-06","current":1008.002687,"twenty":33.204,"median":43.080882,"eighty":103.069186,"marketCap":6048016122},{"date":"2023-04-14","current":951.878212,"twenty":33.370462,"median":43.75,"eighty":103.407118,"marketCap":5711269274},{"date":"2023-04-21","current":998.567518,"twenty":33.596154,"median":43.981617,"eighty":103.793326,"marketCap":5991405106},{"date":"2023-04-28","current":993.314971,"twenty":33.75,"median":44.1875,"eighty":105.06057,"marketCap":5959889825},{"date":"2023-05-05","current":-58.937664,"twenty":33.596154,"median":44.625,"eighty":106.267469,"marketCap":6129517012},{"date":"2023-05-12","current":-62.440245,"twenty":32.86,"median":44.084559,"eighty":105.724364,"marketCap":6493785452},{"date":"2023-05-19","current":-65.370289,"twenty":32.32,"median":43.737133,"eighty":105.06057,"marketCap":6798510012},{"date":"2023-05-26","current":-62.002422,"twenty":31.96,"median":42.617647,"eighty":104.33643,"marketCap":6448251897},{"date":"2023-06-02","current":-61.463563,"twenty":31.821538,"median":42.514706,"eighty":104.09505,"marketCap":6392210598},{"date":"2023-06-09","current":-62.339209,"twenty":31.58,"median":42.077206,"eighty":103.889878,"marketCap":6483277708},{"date":"2023-06-16","current":-66.293409,"twenty":31.276,"median":41.948529,"eighty":103.805395,"marketCap":6894514528},{"date":"2023-06-23","current":-65.720461,"twenty":30.976,"median":41.819853,"eighty":103.757119,"marketCap":6834927976},{"date":"2023-06-30","current":-64.641972,"twenty":30.676,"median":41.639706,"eighty":103.612291,"marketCap":6722765055},{"date":"2023-07-07","current":-66.124895,"twenty":30.496,"median":41.382353,"eighty":103.419187,"marketCap":6876989071},{"date":"2023-07-14","current":-70.745867,"twenty":30.04,"median":41.047794,"eighty":103.370911,"marketCap":7357570126},{"date":"2023-07-21","current":-68.083207,"twenty":29.16,"median":40.417322,"eighty":103.310566,"marketCap":7080653480},{"date":"2023-07-28","current":-65.184615,"twenty":28.46,"median":40.224351,"eighty":103.250221,"marketCap":6779199916},{"date":"2023-08-04","current":-46.934244,"twenty":11.989151,"median":40.172794,"eighty":103.008841,"marketCap":6617728360},{"date":"2023-08-11","current":-45.24292,"twenty":-46.367153,"median":40.069853,"eighty":102.803668,"marketCap":6379251662},{"date":"2023-08-18","current":-47.282457,"twenty":-46.789984,"median":39.889706,"eighty":102.670909,"marketCap":6666826504},{"date":"2023-08-25","current":-46.48654,"twenty":-47.083478,"median":39.863971,"eighty":102.598495,"marketCap":6554602175},{"date":"2023-09-01","current":-44.596237,"twenty":-46.954142,"median":39.477941,"eighty":102.489875,"marketCap":6288069396},{"date":"2023-09-08","current":-42.805423,"twenty":-46.91932,"median":39.194937,"eighty":101.70539,"marketCap":6035564657},{"date":"2023-09-15","current":-44.075686,"twenty":-46.819831,"median":38.577247,"eighty":101.162285,"marketCap":6214671731},{"date":"2023-09-22","current":-41.812206,"twenty":-46.745213,"median":38.371406,"eighty":100.848492,"marketCap":5895520982},{"date":"2023-09-29","current":-41.787332,"twenty":-46.58603,"median":38.268423,"eighty":100.401939,"marketCap":5892013831},{"date":"2023-10-06","current":-42.657902,"twenty":-46.48654,"median":38.011111,"eighty":100.160559,"marketCap":6014764119},{"date":"2023-10-13","current":-41.495014,"twenty":-46.397,"median":37.728022,"eighty":99.496765,"marketCap":5850797012},{"date":"2023-10-20","current":-41.495014,"twenty":-46.292536,"median":37.470588,"eighty":98.941591,"marketCap":5850797012},{"date":"2023-10-27","current":-39.5546,"twenty":-46.262689,"median":37.419198,"eighty":98.845039,"marketCap":5577198591},{"date":"2023-11-03","current":-28.620571,"twenty":-45.939347,"median":36.814417,"eighty":98.181245,"marketCap":5924458126},{"date":"2023-11-10","current":-27.187085,"twenty":-45.665751,"median":35.38,"eighty":97.577795,"marketCap":5627726534},{"date":"2023-11-17","current":-26.577393,"twenty":-45.466771,"median":34.537693,"eighty":97.51745,"marketCap":5501520283},{"date":"2023-11-24","current":-26.187546,"twenty":-45.407077,"median":34.218462,"eighty":97.372622,"marketCap":5420821963},{"date":"2023-12-01","current":-26.119746,"twenty":-45.352358,"median":34,"eighty":96.901932,"marketCap":5406787472},{"date":"2023-12-08","current":-26.001097,"twenty":-45.282716,"median":33.82,"eighty":96.648483,"marketCap":5382227114},{"date":"2023-12-15","current":-26.816149,"twenty":-45.063839,"median":33.408077,"eighty":95.538136,"marketCap":5550942782},{"date":"2023-12-20","current":-26.155068,"twenty":-44.944451,"median":33.2,"eighty":94.862272,"marketCap":5414099060},{"date":"2023-12-29","current":-28.460375,"twenty":-44.825063,"median":33.1,"eighty":94.355374,"marketCap":5891297681},{"date":"2024-01-05","current":-27.799294,"twenty":-44.645982,"median":32.86,"eighty":93.595028,"marketCap":5754453959},{"date":"2024-01-12","current":-25.615193,"twenty":-44.596237,"median":32.48,"eighty":93.474338,"marketCap":5302345051},{"date":"2024-01-19","current":-25.242239,"twenty":-44.476849,"median":32.27,"eighty":93.474338,"marketCap":5225143468},{"date":"2024-01-26","current":-24.479377,"twenty":-44.149949,"median":32.14,"eighty":93.426062,"marketCap":5067231140},{"date":"2024-02-02","current":-23.886041,"twenty":-44.055788,"median":31.91,"eighty":92.834682,"marketCap":4944410441},{"date":"2024-02-09","current":-23.530039,"twenty":-44.009602,"median":31.8,"eighty":92.303646,"marketCap":4870718021},{"date":"2024-02-16","current":-24.145815,"twenty":-43.960915,"median":31.65,"eighty":92.110542,"marketCap":4998183695},{"date":"2024-02-23","current":-23.381483,"twenty":-43.936395,"median":31.47,"eighty":92.050197,"marketCap":6079185648},{"date":"2024-03-01","current":-22.274508,"twenty":-43.896598,"median":31.3,"eighty":92.026059,"marketCap":5791372009},{"date":"2024-03-08","current":-22.261008,"twenty":-43.802079,"median":31.01,"eighty":92.026059,"marketCap":5787862087},{"date":"2024-03-15","current":-21.424266,"twenty":-43.707559,"median":30.7,"eighty":91.881231,"marketCap":5570309186},{"date":"2024-03-22","current":-21.707763,"twenty":-43.588167,"median":30.62,"eighty":91.784679,"marketCap":5644018381},{"date":"2024-03-28","current":-23.233246,"twenty":-43.361893,"median":30.52,"eighty":91.736403,"marketCap":6040644051},{"date":"2024-04-05","current":-21.829262,"twenty":-43.079617,"median":30.28,"eighty":91.663989,"marketCap":5675608036},{"date":"2024-04-12","current":-20.249779,"twenty":-42.991205,"median":29.74,"eighty":91.567437,"marketCap":5264942520},{"date":"2024-04-19","current":-19.354122,"twenty":-42.910921,"median":29.16,"eighty":91.374333,"marketCap":5032071670},{"date":"2024-04-26","current":-19.948802,"twenty":-42.853424,"median":28.79,"eighty":91.253644,"marketCap":5186688398},{"date":"2024-05-03","current":-14.452305,"twenty":-42.81027,"median":28.14,"eighty":91.06054,"marketCap":4870426910},{"date":"2024-05-10","current":-15.943416,"twenty":-42.776263,"median":6.269403,"eighty":90.855367,"marketCap":5372931274},{"date":"2024-05-17","current":-15.89661,"twenty":-42.702674,"median":-14.452305,"eighty":90.69847,"marketCap":5357157713},{"date":"2024-05-24","current":-15.343776,"twenty":-42.558408,"median":-15.176882,"eighty":90.517435,"marketCap":5170852359},{"date":"2024-05-31","current":-16.053073,"twenty":-42.409167,"median":-15.307268,"eighty":90.360538,"marketCap":5409885643},{"date":"2024-06-07","current":-16.161124,"twenty":-42.38555,"median":-15.406361,"eighty":89.708813,"marketCap":5446298879},{"date":"2024-06-14","current":-15.524284,"twenty":-42.291082,"median":-15.524284,"eighty":89.612261,"marketCap":5231683742},{"date":"2024-06-21","current":-15.753964,"twenty":-42.22636,"median":-15.531531,"eighty":89.612261,"marketCap":5309085923},{"date":"2024-06-28","current":-15.419884,"twenty":-42.200231,"median":-15.531531,"eighty":89.588123,"marketCap":5196500933},{"date":"2024-07-05","current":-15.305044,"twenty":-42.160433,"median":-15.442904,"eighty":89.491571,"marketCap":5157799843},{"date":"2024-07-12","current":-16.599891,"twenty":-42.067188,"median":-15.527907,"eighty":89.189846,"marketCap":5594163350},{"date":"2024-07-15","current":-16.641652,"twenty":-42.022409,"median":-15.531531,"eighty":89.177777,"marketCap":5608236717},{"date":"2024-08-02","current":-13.008606,"twenty":-41.97763,"median":-15.527907,"eighty":89.165708,"marketCap":5931924156},{"date":"2024-08-09","current":-12.231452,"twenty":-41.830859,"median":-15.419884,"eighty":89.129501,"marketCap":5577542200},{"date":"2024-08-16","current":-12.424377,"twenty":-41.812206,"median":-15.378124,"eighty":89.105363,"marketCap":5665516052},{"date":"2024-08-23","current":-12.344096,"twenty":-41.802256,"median":-15.333345,"eighty":89.045018,"marketCap":5628907780},{"date":"2024-08-30","current":-12.351816,"twenty":-41.737585,"median":-15.293117,"eighty":88.839845,"marketCap":5632428048},{"date":"2024-09-06","current":-12.266897,"twenty":-41.629375,"median":-15.225285,"eighty":88.562258,"marketCap":5593705105},{"date":"2024-09-13","current":-12.082386,"twenty":-41.495014,"median":-15.135159,"eighty":88.441569,"marketCap":5509567851},{"date":"2024-09-20","current":-15.440748,"twenty":-41.340776,"median":-15.096125,"eighty":88.248465,"marketCap":7040981280},{"date":"2024-09-27","current":-14.699592,"twenty":-40.71764,"median":-15.039289,"eighty":87.850188,"marketCap":6703014178},{"date":"2024-10-04","current":-14.576067,"twenty":-40.669234,"median":-14.803817,"eighty":87.789843,"marketCap":6646686328},{"date":"2024-10-11","current":-14.762545,"twenty":-40.558432,"median":-14.715033,"eighty":87.307083,"marketCap":6731720404},{"date":"2024-10-18","current":-16.160045,"twenty":-40.425462,"median":-14.803817,"eighty":85.170872,"marketCap":7368980547},{"date":"2024-10-25","current":-15.58097,"twenty":-40.03224,"median":-15.03278,"eighty":83.336385,"marketCap":7104922476},{"date":"2024-10-31","current":-19.555605,"twenty":-39.5546,"median":-15.057092,"eighty":82.370866,"marketCap":7196462607},{"date":"2024-11-08","current":-19.378591,"twenty":-39.256075,"median":-15.188745,"eighty":81.465692,"marketCap":7131321506},{"date":"2024-11-15","current":-18.728283,"twenty":-29.051536,"median":-15.28119,"eighty":45.705882,"marketCap":6892008231},{"date":"2024-11-22","current":-18.957961,"twenty":-28.680736,"median":-15.319195,"eighty":45.216912,"marketCap":6976529538},{"date":"2024-11-29","current":-18.967531,"twenty":-28.632604,"median":-15.35573,"eighty":45.093382,"marketCap":6980051259},{"date":"2024-12-06","current":-19.05366,"twenty":-28.492414,"median":-15.406361,"eighty":44.3625,"marketCap":7011746749},{"date":"2024-12-13","current":-17.819143,"twenty":-28.268881,"median":-15.430316,"eighty":44.125735,"marketCap":6557444725},{"date":"2024-12-20","current":-17.17796,"twenty":-28.166769,"median":-15.442904,"eighty":44.089706,"marketCap":6321489410},{"date":"2024-12-27","current":-17.359788,"twenty":-28.057441,"median":-15.524284,"eighty":43.961029,"marketCap":6388402111},{"date":"2025-01-03","current":-17.22581,"twenty":-27.982863,"median":-15.53675,"eighty":43.827206,"marketCap":6339098016},{"date":"2025-01-10","current":-17.302369,"twenty":-27.93327,"median":-15.555604,"eighty":43.744853,"marketCap":6367271784},{"date":"2025-01-17","current":-16.689896,"twenty":-27.795904,"median":-15.616602,"eighty":43.595588,"marketCap":6141881633},{"date":"2025-01-24","current":-16.125272,"twenty":-27.782344,"median":-15.668788,"eighty":43.080882,"marketCap":5934100087},{"date":"2025-01-31","current":-16.890864,"twenty":-27.782344,"median":-15.727669,"eighty":42.617647,"marketCap":6215837776},{"date":"2025-02-07","current":-15.36925,"twenty":-27.577435,"median":-15.753964,"eighty":42.514706,"marketCap":5655884118},{"date":"2025-02-14","current":-15.924304,"twenty":-27.187085,"median":-15.732906,"eighty":42.514706,"marketCap":5860143943},{"date":"2025-02-21","current":-17.668016,"twenty":-27.187085,"median":-15.732906,"eighty":42.35,"marketCap":5600760948},{"date":"2025-02-28","current":-17.567945,"twenty":-27.133247,"median":-15.775561,"eighty":42.144118,"marketCap":5569038576},{"date":"2025-03-07","current":-17.779205,"twenty":-26.960385,"median":-15.89661,"eighty":42.061765,"marketCap":5636008028},{"date":"2025-03-14","current":-16.889689,"twenty":-26.86298,"median":-15.922654,"eighty":41.989706,"marketCap":5354031391},{"date":"2025-03-21","current":-17.51235,"twenty":-26.822637,"median":-15.943416,"eighty":41.953676,"marketCap":5551415037},{"date":"2025-03-28","current":-16.678429,"twenty":-26.814983,"median":-15.997502,"eighty":41.845588,"marketCap":5287061940},{"date":"2025-04-04","current":-14.443519,"twenty":-26.788736,"median":-15.96702,"eighty":41.819853,"marketCap":4578595640},{"date":"2025-04-11","current":-12.586654,"twenty":-26.716571,"median":-15.935916,"eighty":41.799265,"marketCap":3989969410},{"date":"2025-04-17","current":-13.175959,"twenty":-26.687516,"median":-15.922654,"eighty":41.701471,"marketCap":4176778932},{"date":"2025-04-25","current":-15.444225,"twenty":-26.618073,"median":-15.89661,"eighty":41.593382,"marketCap":4895819356},{"date":"2025-05-02","current":-11.310597,"twenty":-26.557919,"median":-15.775561,"eighty":41.454412,"marketCap":4094436190},{"date":"2025-05-09","current":-11.226689,"twenty":-26.52373,"median":-15.732906,"eighty":41.227941,"marketCap":4064061475},{"date":"2025-05-16","current":-11.519559,"twenty":-26.327389,"median":-15.711654,"eighty":41.078676,"marketCap":4170080470},{"date":"2025-05-23","current":-10.982631,"twenty":-26.194896,"median":-15.677723,"eighty":40.754412,"marketCap":3975712312},{"date":"2025-05-30","current":-11.441461,"twenty":-26.187546,"median":-15.667132,"eighty":40.54853,"marketCap":4141808738},{"date":"2025-06-06","current":-11.334075,"twenty":-26.174555,"median":-15.616602,"eighty":40.440476,"marketCap":4102935106},{"date":"2025-06-13","current":-12.144349,"twenty":-26.140939,"median":-15.555604,"eighty":40.291263,"marketCap":4396254326},{"date":"2025-06-20","current":-11.275501,"twenty":-26.103598,"median":-15.541508,"eighty":40.265527,"marketCap":4081731307},{"date":"2025-06-27","current":-11.79397,"twenty":-26.031423,"median":-15.527907,"eighty":40.224334,"marketCap":4269417285},{"date":"2025-07-03","current":-13.562577,"twenty":-26.001097,"median":-15.473992,"eighty":40.224265,"marketCap":4909653018},{"date":"2025-07-11","current":-13.875259,"twenty":-25.848548,"median":-15.440748,"eighty":40.172794,"marketCap":5022843865},{"date":"2025-07-18","current":-13.855717,"twenty":-25.831598,"median":-15.414876,"eighty":40.147059,"marketCap":5015769437},{"date":"2025-07-25","current":-13.650519,"twenty":-25.801671,"median":-15.40753,"eighty":40.069853,"marketCap":4941487944},{"date":"2025-08-01","current":-17.667365,"twenty":-25.780749,"median":-15.406945,"eighty":40.069853,"marketCap":4823190717},{"date":"2025-08-08","current":-17.887721,"twenty":-25.712949,"median":-15.409867,"eighty":39.915441,"marketCap":4883347902},{"date":"2025-08-15","current":-18.250661,"twenty":-25.699956,"median":-15.440748,"eighty":39.889706,"marketCap":4982430323},{"date":"2025-08-22","current":-18.795069,"twenty":-25.6282,"median":-15.444225,"eighty":39.889706,"marketCap":5131053955},{"date":"2025-08-29","current":-18.85988,"twenty":-25.615193,"median":-15.527907,"eighty":39.863971,"marketCap":5148747244},{"date":"2025-09-05","current":-18.911728,"twenty":-25.586031,"median":-15.539129,"eighty":39.863971,"marketCap":5162901876},{"date":"2025-09-12","current":-19.857963,"twenty":-25.538059,"median":-15.555604,"eighty":39.699265,"marketCap":5421223902},{"date":"2025-09-19","current":-19.935736,"twenty":-25.299369,"median":-15.616602,"eighty":39.51397,"marketCap":5442455850},{"date":"2025-09-26","current":-18.626562,"twenty":-25.240228,"median":-15.667132,"eighty":39.375067,"marketCap":5085051402},{"date":"2025-10-03","current":-19.132084,"twenty":-25.211507,"median":-15.69096,"eighty":39.225819,"marketCap":5223059060},{"date":"2025-10-10","current":-18.691372,"twenty":-25.01769,"median":-15.712227,"eighty":39.030164,"marketCap":5102744691},{"date":"2025-10-17","current":-19.261706,"twenty":-24.876065,"median":-15.743435,"eighty":38.680147,"marketCap":5258445639},{"date":"2025-10-24","current":-20.45422,"twenty":-24.761896,"median":-15.797158,"eighty":38.561831,"marketCap":5584002166},{"date":"2025-10-31","current":-17.565666,"twenty":-24.734789,"median":-15.89661,"eighty":38.479541,"marketCap":5357528060},{"date":"2025-11-07","current":-18.034647,"twenty":-24.665855,"median":-15.924304,"eighty":38.389432,"marketCap":5500567345},{"date":"2025-11-14","current":-18.220452,"twenty":-24.513282,"median":-15.949556,"eighty":38.350817,"marketCap":5557237710},{"date":"2025-11-21","current":-16.908207,"twenty":-24.479377,"median":-15.994084,"eighty":38.304428,"marketCap":5157003255},{"date":"2025-11-28","current":-18.80109,"twenty":-24.408177,"median":-16.000919,"eighty":38.263285,"marketCap":5734332602},{"date":"2025-12-05","current":-19.521083,"twenty":-24.350539,"median":-16.021067,"eighty":38.227239,"marketCap":5953930269},{"date":"2025-12-12","current":-20.055271,"twenty":-24.323415,"median":-16.053073,"eighty":38.093431,"marketCap":6116857569},{"date":"2025-12-19","current":-19.625598,"twenty":-24.282647,"median":-16.093827,"eighty":37.995669,"marketCap":5985807349},{"date":"2025-12-26","current":-19.753338,"twenty":-24.255523,"median":-16.123877,"eighty":37.913316,"marketCap":6024768225},{"date":"2026-01-02","current":-19.834628,"twenty":-24.239754,"median":-16.148957,"eighty":37.774346,"marketCap":6049561510},{"date":"2026-01-09","current":-20.090109,"twenty":-24.229496,"median":-16.161124,"eighty":37.635375,"marketCap":6127483263},{"date":"2026-01-16","current":-20.252688,"twenty":-24.209235,"median":-16.445863,"eighty":37.553006,"marketCap":6177069832},{"date":"2026-01-23","current":-19.962368,"twenty":-24.145815,"median":-16.512853,"eighty":37.470588,"marketCap":6088522386},{"date":"2026-01-30","current":-19.567534,"twenty":-23.886041,"median":-16.603767,"eighty":37.419198,"marketCap":5968097860},{"date":"2026-02-06","current":-19.056572,"twenty":-23.806688,"median":-16.632279,"eighty":37.23905,"marketCap":5812254355},{"date":"2026-02-13","current":-19.428181,"twenty":-23.801278,"median":-16.678429,"eighty":36.930226,"marketCap":5925595086},{"date":"2026-02-20","current":-17.365138,"twenty":-23.767836,"median":-16.699466,"eighty":36.744932,"marketCap":6251449687},{"date":"2026-02-27","current":-18.198176,"twenty":-23.752232,"median":-16.818502,"eighty":36.139722,"marketCap":6551343481},{"date":"2026-03-06","current":-17.322223,"twenty":-23.709735,"median":-16.890864,"eighty":35.504,"marketCap":6236000284},{"date":"2026-03-13","current":-16.318321,"twenty":-23.645316,"median":-16.890864,"eighty":35.108,"marketCap":5874595722},{"date":"2026-03-20","current":-15.914792,"twenty":-23.550382,"median":-16.849799,"eighty":34.700308,"marketCap":5729325261},{"date":"2026-03-27","current":-15.639212,"twenty":-23.411194,"median":-16.723391,"eighty":34.491077,"marketCap":5630116166},{"date":"2026-04-02","current":-16.416743,"twenty":-23.36544,"median":-16.694681,"eighty":34.4,"marketCap":5910027542},{"date":"2026-04-10","current":-16.2199,"twenty":-23.281846,"median":-16.661186,"eighty":34.190154,"marketCap":5839163903},{"date":"2026-04-17","current":-16.423299,"twenty":-23.207892,"median":-16.618246,"eighty":34.042769,"marketCap":5912387798},{"date":"2026-04-24","current":-15.621439,"twenty":-23.13519,"median":-16.613337,"eighty":34.008,"marketCap":5623717869},{"date":"2026-05-01","current":-25.874355,"twenty":-23.13519,"median":-16.601829,"eighty":33.988,"marketCap":5666483785},{"date":"2026-05-08","current":-25.890628,"twenty":-23.440905,"median":-16.613587,"eighty":33.884,"marketCap":5670047611},{"date":"2026-05-15","current":-26.487884,"twenty":-23.658878,"median":-16.618246,"eighty":33.778,"marketCap":5800846544},{"date":"2026-05-22","current":-26.292521,"twenty":-23.803442,"median":-16.650988,"eighty":33.657692,"marketCap":5758062181},{"date":"2026-05-29","current":-25.38083,"twenty":-24.19338,"median":-16.678429,"eighty":33.445692,"marketCap":5558401821}],"updateTime":1780222739330},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLCO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1153010785","title":"Earning Preview: Bausch + Lomb Corp. this quarter’s revenue is expected to increase by 5.82%, and institutional views are mostly bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1153010785","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153010785?lang=en_us&edition=fundamental","pubTime":"2026-04-23 10:09","pubTimestamp":1776910189,"startTime":"0","endTime":"0","summary":"Abstract Bausch + Lomb Corp. is scheduled to report quarterly results on April 29, 2026 Pre-Market, and our preview highlights a projected revenue of 1.22 billion US dollars with adjusted EPS near...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Bausch + Lomb Corp. this quarter’s revenue is expected to increase by 5.82%, and institutional views are mostly bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629048452","title":"Bausch + Lomb announces availability of 2025 Sustainability Impact Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629048452","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629048452?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:15","pubTimestamp":1776856557,"startTime":"0","endTime":"0","summary":"Report reaffirmed commitment to achieve Net Zero greenhouse gas emissions by 2050.Decarbonization actions in 2025 included expanded renewable energy use; Scope 3 emissions inventory development.Energy-efficiency work cut compressed-air power demand 10% at Rochester, New York site.Waste-reduction measures included Biotrue ONEday lenses using 50% lighter-weight plastic; shift to electronic Instructions for Use avoided about 25 tons of paper waste since 2023.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief via Business Wire  on April 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL8j5Nxb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626165851","title":"Bausch Health publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2626165851","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626165851?lang=en_us&edition=fundamental","pubTime":"2026-04-10 22:30","pubTimestamp":1775831426,"startTime":"0","endTime":"0","summary":"Bausch Health published its annual report for fiscal year 2025, citing 11th straight quarter of year-over-year growth.Company refinanced USD 9.6 billion of debt to extend maturities and boost financial flexibility.DURECT acquisition added late-stage hepatology asset Larsucosterol, which has FDA Breakthrough Therapy designation for alcohol-associated hepatitis.China aesthetics move brought Shibo Zhenmei distribution business in-house to expand sales and marketing reach in region.Management reiterated plans to separate Bausch + Lomb eye health business, subject to targeted leverage levels and required approvals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate thi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDLcg3cVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625943735","title":"Bausch + Lomb receives FDA 510k clearance for Bi-Blade+","url":"https://stock-news.laohu8.com/highlight/detail?id=2625943735","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625943735?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:16","pubTimestamp":1775646991,"startTime":"0","endTime":"0","summary":"Bausch + Lomb (BLCO) Corporation announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Bi-Blade+ advanced dual-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bausch-lomb-receives-fda-510k-clearance-for-bi-blade-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bausch-lomb-receives-fda-510k-clearance-for-bi-blade-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BLCO","BK4198","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625943809","title":"Bausch + Lomb wins FDA clearance for Bi-Blade+ vitrectomy cutter","url":"https://stock-news.laohu8.com/highlight/detail?id=2625943809","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625943809?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:00","pubTimestamp":1775646054,"startTime":"0","endTime":"0","summary":"FDA granted 510 clearance for Bausch + Lomb Bi-Blade+ dual-port vitrectomy cutter.Agency also cleared Adaptive Fluidics advanced update for Stellaris Elite Vision Enhancement System.Clearances expand Stellaris Elite surgical platform options for vitreoretinal procedures.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief via Business Wire  on April 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL2hYcBm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930587","title":"Bausch + Lomb Launches enVista Envy Intraocular Lenses in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930587","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930587?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563252,"startTime":"0","endTime":"0","summary":"Bausch + Lomb  said Tuesday that the preloaded enVista Envy full range of vision intraocular lenses are now commercially available in Europe.A clinical trial in the US demonstrated that 86.1% of patients reported little to no trouble for dysphotopsia with the enVista Envy intraocular lenses, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625676838","title":"Bausch + Lomb unveils new clinical data on cataract, dry eye portfolio at ASCRS meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2625676838","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625676838?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:01","pubTimestamp":1775473281,"startTime":"0","endTime":"0","summary":"Bausch + Lomb flagged new clinical and real-world evidence across cataract surgery, glaucoma, dry eye, refractive platforms for ASCRS annual meeting in Washington, D.C., April 10-13, 2026.Data will be presented in 45 papers and posters, spanning outcomes tied to full visual range intraocular lenses, minimally invasive glaucoma approaches, and dry eye therapies.Dry eye readouts are set to cover symptom relief and peri-cataract use for Xiidra and Miebo, aiming to support broader adoption in surgical and chronic-care settings.Device-focused studies will review performance and workflow impact for systems including Stellaris Elite, TENEO excimer laser platform, and ScoutPro tear osmolarity testing, targeting efficiency and clinical decision support.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDL4cBGt4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311058","title":"Bausch + Lomb to report first-quarter financial results, host conference call and webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311058","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311058?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:15","pubTimestamp":1774869317,"startTime":"0","endTime":"0","summary":"Bausch + Lomb schedules release of first-quarter 2026 financial results on April 29, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief via Business Wire  on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL1hZGb3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621706787","title":"Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2621706787","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621706787?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:12","pubTimestamp":1774271557,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to higher pre-bell Monday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  up 1.5%.Apogee Therapeutics  stock was up more than 16% after the company said 52-week maintenance data from Part A of its phase two trial of zumilokibart in patients with moderate-to-severe atopic dermatitis demonstrated durable maintenance response and \"deepening\" response for lesional and itch endpoints.Bausch + Lomb  shares were up more than 5% after the company said the US clinical trial of its Elios system for the treatment of elevated intraocular pressure in patients with open angle glaucoma showed statistically significant intraocular pressure reduction after 24 months.Ionis Pharmaceuticals  shares were up more than 1% after the company said the US Food and Drug Administration granted priority review designation for its new drug application for zilganersen as a potential treatment for Alexander disease.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","APGE","XLV","BLCO","LU0053671581.USD","BK4581","BK4139","BK4198","LABU","BK4585","BK4588","XBI","IONS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621777402","title":"Bausch + Lomb reports 24-month U.S. ELIOS glaucoma trial results with 76% achieving ≥20% IOP reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777402","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621777402?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:01","pubTimestamp":1774263702,"startTime":"0","endTime":"0","summary":"Bausch + Lomb reported positive 24-month results from a pivotal U.S. clinical trial of the ELIOS System, an implant-free excimer laser procedure intended to reduce elevated intraocular pressure in open-angle glaucoma.The prospective, multicenter study enrolled 318 patients at 20 U.S. sites who had mild to moderate primary open-angle glaucoma and cataracts.Unmedicated diurnal intraocular pressure was reduced by at least 20% in 76% of patients, and the average decrease was 7.4 mmHg.At 23 months, 82% of patients were medication-free, and no intraoperative complications were reported.Topline results were scheduled to be discussed during a company R&D webinar, and detailed results were slated for submission to a future medical meeting and a peer-reviewed journal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL8ykCYg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621872768","title":"Is Bausch + Lomb’s Glaucoma Focus Reframing Its Innovation Story for Investors (BLCO)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2621872768","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621872768?lang=en_us&edition=fundamental","pubTime":"2026-03-23 14:05","pubTimestamp":1774245915,"startTime":"0","endTime":"0","summary":"Bausch + Lomb recently held a special call to discuss two glaucoma assets and deeper insights into its differentiated product pipeline, following the unveiling of this pipeline in November 2025.\nAlongside this, CEO and Chairman Brenton L. Saunders’ presentation at the Longwood Healthcare Leaders Miami conference highlighted management’s effort to spotlight innovation and future product opportunities to a healthcare-focused investor audience.\nWe will now explore how the focused glaucoma call...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-blco/bausch-lomb/news/is-bausch-lombs-glaucoma-focus-reframing-its-innovation-stor","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-blco/bausch-lomb/news/is-bausch-lombs-glaucoma-focus-reframing-its-innovation-stor","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","BLCO","ISBC","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618495719","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evotec AG (EVO), Shoulder Innovations, Inc. (SI) and Bausch + Lomb Corporation (BLCO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618495719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618495719?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:51","pubTimestamp":1773226278,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evotec AG (EVO – Research Report), Shoulder Innova...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-evotec-ag-evo-shoulder-innovations-inc-si-and-bausch-lomb-corporation-blco-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-evotec-ag-evo-shoulder-innovations-inc-si-and-bausch-lomb-corporation-blco-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4210","BLCO","BK4588","SI","LU0128526141.USD","XLV","XBI","LABU","BK4198","EVO","BK4137","AG","BK4082","BK4121","BK4581","HCSG","LU0029874061.USD","BK4211","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618345959","title":"A Look At Bausch + Lomb (NYSE:BLCO) Valuation As Glaucoma Pipeline Webinar Draws Fresh Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2618345959","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618345959?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:17","pubTimestamp":1773148623,"startTime":"0","endTime":"0","summary":"Bausch + Lomb (BLCO) is drawing fresh attention after announcing an upcoming R&D webinar focused on its glaucoma pipeline, including drug candidate BL1107 and the ELIOS minimally invasive glaucoma surgery platform.\nSee our latest analysis for Bausch + Lomb.\nThe upcoming glaucoma webinar follows a mixed stretch for the stock, with a 1-day share price return of 0.94% and a 7-day share price decline of 6.46%. This sits alongside a 1-year total shareholder return of 8.30% and a 3-year total...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-blco/bausch-lomb/news/a-look-at-bausch-lomb-nyseblco-valuation-as-glaucoma-pipelin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-blco/bausch-lomb/news/a-look-at-bausch-lomb-nyseblco-valuation-as-glaucoma-pipelin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BLCO","BK4198","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617572377","title":"Cooper Companies raises 2026 profit forecast on demand for disposable contact lenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2617572377","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617572377?lang=en_us&edition=fundamental","pubTime":"2026-03-06 06:52","pubTimestamp":1772751165,"startTime":"0","endTime":"0","summary":"Cooper Companies raises 2026 profit forecast on demand for disposable contact lenses  March 5 (Reuters) - Cooper Companies COO.O raised its annual profit forecast on Thursday, betting on strong demand","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL4N3ZT27O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2211815571.USD","BK4588","BK4198","LU2272731600.USD","COO","LU1992135472.HKD","BLCO","LU2272731782.SGD","GB00BDT5M118.USD","LU1992135399.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617549923","title":"Morgan Stanley Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617549923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617549923?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:36","pubTimestamp":1772710602,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Patrick Wood maintained a Buy rating on Bausch + Lomb Corporation on March 3 and set a price target of $21.00. The company’s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-buy-rating-for-bausch-lomb-corporation-blco-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-buy-rating-for-bausch-lomb-corporation-blco-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616930377","title":"Bausch + Lomb Director Andrew C. von Eschenbach Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2616930377","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616930377?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:18","pubTimestamp":1772576336,"startTime":"0","endTime":"0","summary":"Andrew C. von Eschenbach, a director, reported an acquisition of common shares of Bausch + Lomb Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL2WnZcQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bausch + Lomb Director Andrew C. von Eschenbach Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614030401","title":"US Treasury chief says FedEx should say how consumers will get tariff rebates","url":"https://stock-news.laohu8.com/highlight/detail?id=2614030401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614030401?lang=en_us&edition=fundamental","pubTime":"2026-02-26 02:40","pubTimestamp":1772044839,"startTime":"0","endTime":"0","summary":"US Treasury chief says FedEx should say how consumers will get tariff rebatesBy Susan Heavey and Lisa Baertlein","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL1N3ZL0WT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930227.SGD","BK4198","LU0048573561.USD","LU0128525689.USD","LU1571399168.USD","LU0052756011.USD","LU0742534661.SGD","BK4588","LU0251131958.USD","BK4533","LU0310800965.SGD","LU0251142724.SGD","BK4131","FDX","BK4585","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614235297","title":"Bausch + Lomb Director Steven H. Collis Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614235297","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614235297?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:24","pubTimestamp":1771968274,"startTime":"0","endTime":"0","summary":"Steven H. Collis, a director of Bausch + Lomb Corp., reported an acquisition of the company’s common shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL8Tx5Hm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bausch + Lomb Director Steven H. Collis Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614974797","title":"L'Oreal, Dyson, Bausch + Lomb become the latest to sue for Trump tariff refunds","url":"https://stock-news.laohu8.com/highlight/detail?id=2614974797","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614974797?lang=en_us&edition=fundamental","pubTime":"2026-02-25 04:30","pubTimestamp":1771965047,"startTime":"0","endTime":"0","summary":"L'Oreal, Dyson, Bausch+ Lomb become the latest to sue for Trump tariff refundsCompanies are among the highest-profile to join tariff legal challengeMore than 1,000 lawsuits filed since Liberation Day last yearBy Arriana McLymore. NEW YORK, Feb 24  - French beauty group L'Oreal OREP.PA, British vacuum manufacturer Dyson and contact lens maker Bausch + Lomb BLCO.TO became the latest corporations to sue for refunds of tariffs paid under President Donald Trump’s emergency trade measures, days after the U.S. Supreme Court ruled the duties unlawful, court filings showed.The cases were filed on Monday in the U.S. Court of International Trade, adding them to a growing list of prominent companies to file suit following Friday's landmark ruling. Global transportation company FedEx FDX.N and U.S. skincare and fragrance company Sol de Janeiro also filed complaints this week. More than 1,400 importers including big-box retailer Costco COST.O and tiremaker Goodyear GT.O have already sued, court docu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL6N3ZK1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU0742534661.SGD","IE00BKVL7J92.USD","LU0471298777.SGD","BLCO","LU1066053197.SGD","LU1496350502.SGD","LU1267930227.SGD","LU1323610961.USD","BK4504","BK4131","LU2210149790.SGD","BK4596","LU2097829019.USD","LRLCY","LU0823434583.USD","LU0265550359.USD","BK4155","LU0052756011.USD","LU1551013425.SGD","LU1496350171.SGD","LU2360106947.USD","LU0128525689.USD","LU2125154935.USD","BK4588","LU2095319765.USD","LU2168564149.EUR","BK4585","LU2125154778.USD","LU1551013342.USD","LU0256863811.USD","LU1035775433.USD","LU0238689110.USD","BK1601","LU0310800965.SGD","BK4533","LU0417517546.SGD","BK1602","LU1066051225.USD","BK4119","BK1525","LU1116320737.USD","LU1069344957.HKD","LU0385154629.USD","LU0820561818.USD","LU1571399168.USD","LU0234570918.USD","BK1502","LU2168563687.JPY","LU2168564222.USD","LU0471298694.HKD","LU0943347566.SGD","BK4550","LU1066051811.HKD","LU2237438978.USD","IE0008368304.USD","LU0265550946.USD","LU0823434740.USD","LU2210150020.SGD","BK1577","LU0251142724.SGD","LU0234572021.USD","LU2168564065.EUR","LU0079474960.USD","LU0048573561.USD","LU1116320901.HKD","BK1224","LU1066051498.USD","COSW","LU2381873111.SGD","BK4581","COTG","LU0251131958.USD","LU2168564495.EUR","IE00BZ1G4Q59.USD","IE00B5TLWC47.USD","LU0689472784.USD","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613171566","title":"Study finds Bausch + Lomb’s LUMIFY reduces eye redness without rebound or tachyphylaxis","url":"https://stock-news.laohu8.com/highlight/detail?id=2613171566","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613171566?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934432,"startTime":"0","endTime":"0","summary":"Bausch + Lomb Corp. said Ophthalmology and Therapy has published a new global narrative review on noninfectious conjunctival hyperemia , describing rising prevalence linked to digital eye strain, dry eye, contact lens use, allergies and environmental factors. The published review summarizes evidence that brimonidine tartrate 0.025%  reduced redness without tachyphylaxis over 29 days and with virtually no rebound redness after discontinuation, and it also cites comparable findings for a preservative-free brimonidine 0.025% formulation. The company also noted it introduced LUMIFY Preservative Free Eye Drops in single-use vials in 2025. Results have already been published.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL10B4mt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":75,"code":"91000000","status":"200"}]}}